Amelie Wuppermann’s Post

🌟 Exciting News! 🌟 Rohan Kulkarni, our Executive Research Leader for Healthcare & Life Sciences, has just published a compelling article in Medical Economics. In his latest piece, Rohan explores how combining traditional primary care with consumer technologies can revolutionize healthcare delivery. The result can be improved outcomes across the quadruple aim of care—reducing the cost of care, enhancing the experience of care, improving health outcomes, and addressing health equities. Rohan's insights, backed by two decades of industry experience, position him as a thought leader in healthcare innovation. Don't miss this must-read article that offers a glimpse into the future of healthcare! 👉 Read the full article here: https://lnkd.in/gQK4ujyg Rohan Kulkarni │ Phil Fersht │ Saurabh Gupta │ Tony Filippone │ Elena Christopher #HealthcareInnovation #EmergingTechnologies #QuadrupleAim #HFSResearch

ICYMI - last week at Prova Health we published our latest white paper on economic evidence generation for digital health solutions! 💰 📊 Economic evidence is arguably the most crucial type of evidence for digital health innovators. It is vital for decision makers to determine whether a digital health solution can be funded through investment, adopted by patients and clinicians, and reimbursed by payors. Can you demonstrate the value of your technology, as funding for digital health solutions gets tighter? Read the latest Prova Health white paper, developed in collaboration with York Health Economics Consortium and leading health economics experts: https://lnkd.in/dhh3UQ3c To find out how we can help you generate the economic evidence you need, get in touch!

Your guide to Making the Digital Health Revolution. I wrote this book to explore 1] Whether Revolutions might have a 'Structure' that can be observed and codified 2] Whether we can follow Revolutions in real-time and 3] What logical methods are being used within the field to justify decision making. As Hart & Sacks remind us: the human experience recurs in patterns. This interest led to 4 years of research and 1 year of writing. Jack Murtha and Tom Castles edited the book, and guest writers contributed to their own fascinating chapter! Thanks everyone for your feedback and ideas. Hard copy book coming soon. Unlock your imagination here: https://lnkd.in/gWrWzisk ‐----------------------- *COMMENTS/REVIEWS* We are delighted to see the impact the book is having on the industry. “The health tech must read!” John Nosta, Founder of NostaLab “Interested in #DigitalHealth? This is it then!!” – Rafael J. Grossmann, MD, FACS, Trauma Surgeon & Digital Health Innovator “Fantastic book by TAMP Advisory Board Member in Global Health Law & Philosophy & Digital Health Expert, Bianca Rose Phillips LLB. BComm. GradDipLP. LLM.! It is packed with deep insights, immense value and immediately applicable wisdom! Highly recommend picking it up!” – David A. Hall MA, MHA, PMP, MIS/IT, CEO of TAMP "This book is up there with the classics, like Thomas Kuhn's - Structure of Scientific Revolutions or Karl Popper's - Logic of Scientific Discovery." Tom Castles, Digital Health Journalist & Editor "Phillips does a wonderful job analyzing the mechanisms of change in this book. She goes beyond the headlines and hype that are inherent to digital health and cracks what's really at stake and really at play." Jack Murtha, Digital Health Journalist & Editor “Bianca Rose Phillips wrote the book." Thomas Hickey, MedTech Gurus Podcast

Bredec Group Bredec Ecosystem Experts map and describe health research digital ecosystem in Queensland: Queensland's Health Research Digital Ecosystem Capability Statement will enable health researchers to better navigate the health and medical research ... inquiry@bredec.com Inquiry@bredec.com

Welcome to Sheffield Centre for Health And Related Research (SCHARR) Outcomes Group! Here at SCHARR Outcomes, we are global leaders in developing and applying Patient-Reported Outcome Measures (PROMs) to improve healthcare decision-making and enhance patient care. Our expertise spans: ✅ Developing PROMs through both qualitative and quantitative methods ✅ Creating and valuing generic and condition-specific utility measures ✅ Generating QALYs (Quality-Adjusted Life Years) to inform health outcomes ✅ Developing measures for carers and social care users ✅ Integrating utility measures into cost-effectiveness models ✅ Using advanced techniques to map PROMs to utility measures We are committed to driving innovation in health economics and contributing to policies that improve both patient and caregiver outcomes. Let's collaborate to shape the future of patient-centred research! 💡 #PROMs #HealthEconomics #QALY #PatientOutcomes #SocialCare #CostEffectiveness #HealthcareInnovation

🔊 🔊 I am very happy to announce the publication of a new research paper in Social Science & Medicine, written together with Dane Pflueger and Christian Huber, which explores the commercial interests of Evaluative Health Platforms (EHPs) and their impact on patient voice. 🌐🔍 We analyzed 71 platforms across the USA, UK, and Germany, unveiling five distinct types: subscribers, analyzers, advertisers, regulators, and scammers. Each type employs a unique competitive strategy, influencing patient voice. Our study offers three key insights: 💡 We provide nuance to universalizing claims about platform capitalism, highlighting diverse strategies shaping competition among EHPs in different countries. 💡 We show how patients can navigate the complexities of EHPs by making informed choices between platforms, empowering themselves amidst a rapidly changing business context. 💡 We outline the prerequisites for platforms to become empowering, emphasizing the importance of informed choice and transparency. For those interested in learning more, the open access full paper is available here: https://lnkd.in/etXEHm_a University of Groningen Faculty of Economics and Business - University of Groningen Accounting Research Programme - University of Groningen #platforms #evaluation #business #competition #patients #empowerment #voice #rankings #moderation

The importance of Health Economics and Outcomes Research (HEOR) in informed decision making in healthcare has never been greater. The new ISPOR’s strategy addresses the biggest challenges: 📌 Affordability and its impact on the long-term sustainability of healthcare systems. 📌 Digital Health and its influence on the transformation of healthcare. 📌 Whole Health and its potential to improve the wellbeing of people across the globe. ISPOR—The Professional Society for Health Economics and Outcomes Research Strategic Plan 2030 presents a bold new vision for the Society and for HEOR. 👉 https://lnkd.in/dtCSSdMe

Our Health Systems Are Falling Behind the Pace of Scientific Innovation. What if healthcare would not just be a cost, but a strategic investment in our well-being and prosperity? This is not a utopian dream but could be a reality soon with the power of scientific innovation. The last century, one-third of economic growth in advanced economies was attributed to improvements in health. In developing countries, for every $1 invested in health, an economic return of between $2 to $4 has been found. Yet, these statistics are often overlooked. With a new era of science and innovation, there is a potential to fully change how healthcare is designed, developed, and delivered. Digital innovation, data, and AI are transforming what once may have sounded like science fiction into a fast-approaching reality. Science is racing forward, but the health systems are falling behind. Under-resourced and over-burdened, too many health systems are struggling to address the changing burdens of disease driven by a rise in chronic conditions and worsened by the devastating impact of the climate crisis on health. We need to recognize that investment in health is a strategic investment in our current and future well-being and prosperity. Let’s start investing in tools like digital health, AI health, and data insights. Not only for the short term benefit of patients, but also for the long term benefit of improved health. 

The challenges impeding the responsible development and implementation of digital health technologies needs to be looked at closely through an evidence based lense. The use of a participatory research methodology to gather insights from a diverse group of digital health stakeholders is also important. It not only brings to light the fragmented knowledge existing within the digital health ecosystem but also emphasizes the importance of stakeholder collaboration in navigating ethical, regulatory, and practical hurdles. There is a call for a more collaborative, ethical, and well-regulated approach to digital health innovation resonates with the broader healthcare objectives of improving patient outcomes and addressing systemic inefficiencies. By doing so, not only identifies key impediments, but also sets the stage for future research directions and policy discussions. https://lnkd.in/eKFYCnnf

🚨🚨🚨 New white paper from @Prova Health 🚨🚨🚨 ➡ Generating economic evidence for digital health solutions ⬅ We work and interact with dozens of digital health companies, large and small. One trend has clearly emerged in the past few years from our discussions on evidence: everyone needs economic evidence. Customers and investors want proof of the value for money of digital health solutions. But how can you generate economic evidence? The white paper is a primer on this topic. We hope it will be a helpful read and that it will spark conversations among digital health stakeholders. 📖📖📖 You can read it here: https://lnkd.in/d57-AEcm 📖📖📖 Let us know what you think! Thanks to all that contributed, starting with Dr Saira Ghafur who led the work: Des Conroy, Owen Bray, Abbi G-Medhin, Lane Deamant, Dr Jack Halligan, York Health Economics Consortium, Divya Srivastava, Simon Reif, Angel Varghese, Robert Malcolm, Hayden Holmes